Great Lakes Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Sell
1,122
-713
-39% -$197K ﹤0.01% 750
2026
Q1
$542K Sell
1,835
-22
-1% -$6.54K ﹤0.01% 582
2025
Q4
$507K Buy
1,857
+243
+15% +$66K ﹤0.01% 610
2025
Q3
$436K Sell
1,614
-96
-6% -$26.1K ﹤0.01% 642
2025
Q2
$471K Buy
1,710
+49
+3% +$13.3K ﹤0.01% 617
2025
Q1
$441K Buy
1,661
+37
+2% +$9.13K ﹤0.01% 622
2024
Q4
$377K Buy
1,624
+75
+5% +$17.2K ﹤0.01% 689
2024
Q3
$342K Sell
1,549
-898
-37% -$186K ﹤0.01% 709
2024
Q2
$481K Sell
2,447
-8,459
-78% -$1.75M ﹤0.01% 662
2024
Q1
$2.35M Sell
10,906
-6,600
-38% -$1.39M 0.02% 455
2023
Q4
$3.69M Buy
17,506
+2,739
+19% +$584K 0.04% 378
2023
Q3
$2.96M Buy
14,767
+4,027
+37% +$800K 0.03% 410
2023
Q2
$1.99M Sell
10,740
-2
-0% -$370 0.02% 448
2023
Q1
$2.06M Buy
10,742
+8
+0.1% +$1.45K 0.02% 497
2022
Q4
$1.81M Buy
10,734
+128
+1% +$22.2K 0.1% 312
2022
Q3
$1.88M Buy
10,606
+2
+0% +$395 0.04% 356
2022
Q2
$2.17M Buy
10,604
+497
+5% +$105K 0.04% 351
2022
Q1
$2.4M Sell
10,107
-4
-0% -$939 0.04% 356
2021
Q4
$2.31M Sell
10,111
-199
-2% -$43.8K 0.04% 360
2021
Q3
$1.99M Sell
10,310
-198
-2% -$40.1K 0.03% 380
2021
Q2
$2.23M Sell
10,508
-325
-3% -$68.6K 0.03% 376
2021
Q1
$2.21M Sell
10,833
-2,471
-19% -$487K 0.04% 370
2020
Q4
$2.42M Sell
13,304
-24,476
-65% -$4.16M 0.04% 344
2020
Q3
$6.32M Buy
37,780
+20,592
+120% +$3.47M 0.13% 188
2020
Q2
$2.79M Buy
17,188
+317
+2% +$56.8K 0.07% 285
2020
Q1
$2.92M Buy
16,871
+620
+4% +$123K 0.09% 253
2019
Q4
$3.26M Sell
16,251
-2,023
-11% -$415K 0.07% 285
2019
Q3
$3.86M Sell
18,274
-891
-5% -$186K 0.08% 259
2019
Q2
$3.72M Buy
19,165
+1,462
+8% +$270K 0.08% 244
2019
Q1
$2.91M Sell
17,703
-27,066
-60% -$4.78M 0.06% 286
2018
Q4
$8.42M Buy
44,769
+11,846
+36% +$2.19M 0.2% 123
2018
Q3
$5.6M Sell
32,923
-6,846
-17% -$1.15M 0.12% 172
2018
Q2
$6.52M Buy
39,769
+28,598
+256% +$4.67M 0.15% 151
2018
Q1
$1.81M Sell
11,171
-9,501
-46% -$1.51M 0.04% 325
2017
Q4
$3.02M Sell
20,672
-18
-0.1% -$2.56K 0.07% 248
2017
Q3
$2.81M Sell
20,690
-5,363
-21% -$677K 0.07% 247
2017
Q2
$3.26M Sell
26,053
-22,770
-47% -$2.72M 0.08% 210
2017
Q1
$5.8M Sell
48,823
-20,312
-29% -$2.44M 0.15% 119
2016
Q4
$7.97M Sell
69,135
-29,902
-30% -$3.33M 0.21% 78
2016
Q3
$10.4M Buy
99,037
+1,108
+1% +$116K 0.28% 61
2016
Q2
$9.54M Buy
97,929
+63,014
+180% +$5.95M 0.26% 71
2016
Q1
$3.35M Buy
34,915
+23,346
+202% +$2.12M 0.09% 202
2015
Q4
$1.05M Sell
11,569
-165
-1% -$15.5K 0.03% 326
2015
Q3
$1.09M Sell
11,734
-32
-0.3% -$3.04K 0.03% 314
2015
Q2
$1.09M Sell
11,766
-3,402
-22% -$317K 0.03% 314
2015
Q1
$1.44M Sell
15,168
-5,237
-26% -$485K 0.04% 283
2014
Q4
$1.81M Buy
20,405
+2,025
+11% +$172K 0.06% 236
2014
Q3
$1.47M Sell
18,380
-17,172
-48% -$1.29M 0.05% 243
2014
Q2
$2.52M Sell
35,552
-4,700
-12% -$331K 0.1% 105
2014
Q1
$2.98M Sell
40,252
-5,078
-11% -$383K 0.13% 94
2013
Q4
$3.56M Sell
45,330
-4,101
-8% -$321K 0.16% 70
2013
Q3
$3.65M Buy
49,431
+1,600
+3% +$118K 0.16% 82
2013
Q2
$3.63M Buy
+47,831
New +$3.14M 0.17% 77

Other funds holding CME

Great Lakes Advisors's CME Position: Q2 2026 in Review

Great Lakes Advisors reduced its CME Group (CME) stake by 39% in Q2 2026, selling an estimated $197K and leaving 1,122 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

Great Lakes Advisors first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.4M in Q3 2016. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Great Lakes Advisors held 1,122 shares of CME Group worth $248K as of Q2 2026.
  • Great Lakes Advisors sold 713 CME Group shares in Q2 2026, an estimated $197K.
  • CME Group made up ﹤0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #750 holding.
  • Great Lakes Advisors first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Great Lakes Advisors's CME Group position peaked at $10.4M in Q3 2016.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.